Submission for OMB Review; 30-Day Comment Request: Generic Clearance for Satisfaction Surveys of Customers (CSR), 64202-64203 [2014-25601]
Download as PDF
<![CDATA[
64202
Federal Register / Vol. 79, No. 208 / Tuesday, October 28, 2014 / Notices
withdrawn from sale for reasons of
safety or effectiveness.
Accordingly, the Agency will
continue to list DIAMOX
(acetazolamide) intravenous, 500 mg
base/vial, and DIAMOX (acetazolamide)
tablets, 125 mg and 250 mg, in the
‘‘Discontinued Drug Product List’’
section of the Orange Book. The
‘‘Discontinued Drug Product List’’
delineates, among other items, drug
products that have been discontinued
from marketing for reasons other than
safety or effectiveness. FDA will not
begin procedures to withdraw approval
of ANDAs that refer to DIAMOX
(acetazolamide) intravenous, 500 mg
base/vial, and DIAMOX (acetazolamide)
tablets, 125 mg and 250 mg. Additional
ANDAs that refer to these products may
also be approved by the Agency as long
as they meet all other legal and
regulatory requirements for the approval
of ANDAs. If FDA determines that
labeling for these drug products should
be revised to meet current standards, the
Agency will advise ANDA applicants to
submit such labeling.
Dated: October 21, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–25534 Filed 10–27–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: Generic Clearance
for Satisfaction Surveys of Customers
(CSR)
Under the provisions of
Section 3507(a)(l)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
SUMMARY:
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on August 21,
2014, page 49523 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The Center
for Scientific Review (CSR), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 31, 2014, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project
contact: Dr. Mary Ann Guadagno,
Project Clearance Liaison, Center for
Scientific Review, NIH, Room 3182,
6701 Rockledge Drive, Bethesda, MD
20892, or call non-toll-free number (301)
435–1251 or Email your request,
including your address to: guadagma@
csr.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Generic
Clearance for Satisfaction Surveys of
Customers (CSR), 0925–0474—
extension, Center for Scientific Review
(CSR), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The information collected in
these surveys will be used by the Center
for Scientific Review management and
personnel: (1) To assess the quality of
the modified operations and processes
now used by CSR to review grant
applications; (2) To assess the quality of
service provided by CSR to our
customers; (3) To enable identification
of the most promising biomedical
research that will have the greatest
impact on improving public health by
using a peer review process that is fair
unbiased from outside influence, timely,
and (4) To develop new modes of
operation based on customer need and
customer feedback about the efficacy of
implemented modifications. These
surveys will almost certainly lead to
quality improvement activities to
enhance and/or streamline CSR’s
operations. The major mechanism by
which CSR will request input is through
surveys. The major initiatives ongoing at
the present time include: Evaluation of
the peer review process, surveys of new
and early stage investigators,
satisfaction with study section meetings
using alternative review platforms,
quick feedback for peer review,
satisfaction with new reviewer
orientation sessions, teleworker space
needs, improving study section
alignment to ensure the best reviews,
and others. Surveys will be collected via
Internet or in focus groups. Information
gathered from these surveys will be
presented to, and used directly by, CSR
management to enhance the operations,
processes, organization of, and services
provided by the Center.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
4323.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
A ...............
B ...............
asabaliauskas on DSK4SPTVN1PROD with NOTICES
Form name
Adult scientific professionals (via Mail/Telephone/Internet) ......
Adult scientific professionals (via focus groups) .......................
VerDate Sep<11>2014
20:06 Oct 27, 2014
Jkt 235001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
7925
240
E:\FR\FM\28OCN1.SGM
Average
burden per
response
(in hours)
1
1
28OCN1
30/60
90/60
Total annual
burden hour
3963
360
Federal Register / Vol. 79, No. 208 / Tuesday, October 28, 2014 / Notices
64203
Dated: October 20, 2014.
Mary Ann Guadagno,
Project Clearance Liaison, Center for
Scientific Review, National Institutes of
Health.
Dated: October 22, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–25505 Filed 10–27–14; 8:45 am]
[FR Doc. 2014–25601 Filed 10–27–14; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Cancer Institute; Notice of
Meeting
asabaliauskas on DSK4SPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel.
Date: December 11, 2014.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: Connected Health: Improving
Patients’ Engagement and Activation for
Cancer-Related Health.
Place: Royal Sonesta Hotel Boston, 40
Edwin Land Blvd., Cambridge, MA 02142.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, President’s Cancer
Panel, Special Assistant to the Director, NCI
Center for Cancer Research, 9000 Rockville
Pike, Building 31, Room B2B37, MSC 2590,
Bethesda, MD 20892–8349, (301) 451–9399,
sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
VerDate Sep<11>2014
20:06 Oct 27, 2014
Jkt 235001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: November 18–19, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree by Hilton Bethesda—
Washington, DC, 8120 Wisconsin Avenue,
Bethesda, MD 20814, 301–664–7310, Fax:
301–664–7317.
Contact Person: Susana Mendez, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/NIH/NIAID, 5601 Fishers Lane, MSC
9823, Rockville, MD 20852, 240–669–5077,
Fax: 301–480–2408, susana.mendez@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 22, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–25509 Filed 10–27–14; 8:45 am]
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Division of Allergy,
Immunology and Transplantation: Statistical
and Clinical Coordinating Center.
Date: November 17, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fisher Lane, MSC 9823, Room 3F100,
Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 5601
Fisher Lane, MSC 9823, Rockville, MD
20852, 240–669–5067, PAmstad@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 22, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–25507 Filed 10–27–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
BILLING CODE 4140–01–P
PO 00000
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\28OCN1.SGM
28OCN1
]]>Agencies
[Federal Register Volume 79, Number 208 (Tuesday, October 28, 2014)]
[Notices]
[Pages 64202-64203]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25601]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: Generic
Clearance for Satisfaction Surveys of Customers (CSR)
SUMMARY: Under the provisions of Section 3507(a)(l)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH) has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on August 21, 2014, page 49523 and allowed 60 days for public
comment. No public comments were received. The purpose of this notice
is to allow an additional 30 days for public comment. The Center for
Scientific Review (CSR), National Institutes of Health, may not conduct
or sponsor, and the respondent is not required to respond to, an
information collection that has been extended, revised, or implemented
on or after October 31, 2014, unless it displays a currently valid OMB
control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project contact: Dr. Mary Ann
Guadagno, Project Clearance Liaison, Center for Scientific Review, NIH,
Room 3182, 6701 Rockledge Drive, Bethesda, MD 20892, or call non-toll-
free number (301) 435-1251 or Email your request, including your
address to: guadagma@csr.nih.gov. Formal requests for additional plans
and instruments must be requested in writing.
Proposed Collection: Generic Clearance for Satisfaction Surveys of
Customers (CSR), 0925-0474--extension, Center for Scientific Review
(CSR), National Institutes of Health (NIH).
Need and Use of Information Collection: The information collected
in these surveys will be used by the Center for Scientific Review
management and personnel: (1) To assess the quality of the modified
operations and processes now used by CSR to review grant applications;
(2) To assess the quality of service provided by CSR to our customers;
(3) To enable identification of the most promising biomedical research
that will have the greatest impact on improving public health by using
a peer review process that is fair unbiased from outside influence,
timely, and (4) To develop new modes of operation based on customer
need and customer feedback about the efficacy of implemented
modifications. These surveys will almost certainly lead to quality
improvement activities to enhance and/or streamline CSR's operations.
The major mechanism by which CSR will request input is through surveys.
The major initiatives ongoing at the present time include: Evaluation
of the peer review process, surveys of new and early stage
investigators, satisfaction with study section meetings using
alternative review platforms, quick feedback for peer review,
satisfaction with new reviewer orientation sessions, teleworker space
needs, improving study section alignment to ensure the best reviews,
and others. Surveys will be collected via Internet or in focus groups.
Information gathered from these surveys will be presented to, and used
directly by, CSR management to enhance the operations, processes,
organization of, and services provided by the Center.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 4323.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total annual
Form name Type of respondent respondents responses per response (in burden hour
respondent hours)
----------------------------------------------------------------------------------------------------------------
A................... Adult scientific 7925 1 30/60 3963
professionals (via Mail/
Telephone/Internet).
B................... Adult scientific 240 1 90/60 360
professionals (via focus
groups).
----------------------------------------------------------------------------------------------------------------
[[Page 64203]]
Dated: October 20, 2014.
Mary Ann Guadagno,
Project Clearance Liaison, Center for Scientific Review, National
Institutes of Health.
[FR Doc. 2014-25601 Filed 10-27-14; 8:45 am]
BILLING CODE 4140-01-P
